Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

5 ML ELOSULFASE ALFA 1 MG/ML Injection [Vimizim]

Known as: Vimizim 5 MG in 5 ML Injection, 5 ML Vimizim 1 MG/ML Injection, ELOSULFASE ALFA 5 mg in 5 mL INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE [VIMIZIM] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Introduction Enzyme replacement therapies (ERTs) are expensive drugs that can be used to treat certain inherited diseases. ERTs… Expand
Review
2017
Review
2017
ABSTRACT Introduction: Mucopolysaccharidosis IVA (Morquio A syndrome) is an inherited, autosomal recessive disease caused by a… Expand
Review
2014
Review
2014
Elosulfase alfa (Vimizim®) is a recombinant form of the human lysosomal enzyme N-acetylgalactosamine-6-sulfatase (GALNS) that is… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
2014
2014
Elosulfase alfa (Vimizim™) is a recombinant form of N-acetylgalactosamine-6-sulfatase (GALNS) that was developed by BioMarin… Expand